A Phase I/II Study of CR011-vcMMAE in Subjects With Unresectable Stage III or Stage IV Melanoma

Clinical trial NCT00412828 · COMPLETED

Trial details

NCT number: NCT00412828
Sponsor: CuraGen Corporation
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Unresectable Stage III or Stage IV Melanoma

Start date: 2006-06-01
Primary completion: 2010-12-01
Enrollment: 117

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.